Treatment of insomnia: a review and update

References

• Doghramji PP. Treatment of insomnia with zaleplon, a novel sleep medication. Int. J. Clin. Pract. 55, 329–334 (2001).
   PubMed Web of Science ®Google Scholar
• Katz DA, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. J. Fam. Pract. 51, 229–235 (2002).
   PubMed Web of Science ®Google Scholar
• Smith MT, Neubauer DN. Cognitive behavior therapy for chronic insomnia. Clin. Cornerstone 5, 28–40 (2003).
   PubMedGoogle Scholar
• Roth T, Roehrs T. Insomnia: epidemiology, characteristics, and consequences. Clin. Cornerstone 5, 5–15 (2003).
   PubMedGoogle Scholar
• Drake CL, Roehrs T, Roth T. Insomnia causes, consequences, and therapeutics: an overview. Depress. Anxiety 18, 163–176 (2003).
   PubMed Web of Science ®Google Scholar
• Kapur VK, Redline S, Nieto FJ et al. The relationship between chronically disrupted sleep and healthcare use. Sleep 25, 289–296 (2002).
   PubMed Web of Science ®Google Scholar
• Lippmann S, Mazour I, Shahab H. Insomnia: therapeutic approach. South Med. J. 94, 866–873 (2001).
   PubMed Web of Science ®Google Scholar
• Hirst A, Sloan R. Benzodiazepines and related drugs for insomnia in palliative care. Cochrane Database Syst. Rev. 4 (2002).
   PubMedGoogle Scholar
• Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention. JAMA 262, 1479–1484 (1989)
   PubMed Web of Science ®Google Scholar
• Breslau N. Roth T, Rosenthal L et al. Steep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol. Psychiatry 39, 411–418 (1996)
   PubMed Web of Science ®Google Scholar
• Ohayon MM, Caulet M, Arbus L et al. Are prescribed medications effective in the treatment of insomnia complaints? J. Psychosom. Res. 47, 359–368 (1999).
   PubMed Web of Science ®Google Scholar
• Livingston G. Blizard B. Mann A. Does sleep disturbance predict depression in elderly people? A study in inner London. Br. J. Gen. Pract. 43, 445–448 (1993).
   PubMed Web of Science ®Google Scholar
• Weissman MM. Greenwald S, Nino-Murcia G et al. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen. Hosp. Psychiatry. 19, 245–250 (1997).
   PubMed Web of Science ®Google Scholar
• Eaton WM, Badawi M, Melton B. Prodromes and precursors; Epidemiologic data for primary prevention of disorders with slow onset. Am. J. Psychiatry 152, 967–72 (1995).
   PubMed Web of Science ®Google Scholar
• Buysse DJ. Insomnia, depression and aging. Assessing sleep and mood interactions in older adults. Geriatrics 59, 47–51 (2004)
   PubMed Web of Science ®Google Scholar
• Riemann D, Vodeholzer U. Primary insomnia: a risk factor to develop depression? J.Affect. Disord. 76, 255–259 (2003).
   PubMed Web of Science ®Google Scholar
• Lustberg L, Reynolds CF Depression and insomnia: questions of cause and effect. Sleep Med. Rev. 4, 253–262 (2000).
   PubMed Web of Science ®Google Scholar
• Smith MT, Perlis ML, Park A et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am. J. Psychiatry 159, 5–11 (2002).
   PubMed Web of Science ®Google Scholar
• Jindal RD, Buysse DJ, Thase ME. Maintenance treatment of insomnia: what can we learn from the depression literature? Am. J. Psychiatry 161, 19–24 (2004).
   PubMed Web of Science ®Google Scholar
• Benca RM. Diagnosis and treatment of chronic insomnia: a review. Psychiatr. Serv. 56, 332–343 (2005).
   PubMed Web of Science ®Google Scholar
• Busto UE, Sproule BA, Knight K et al. Use of prescription and nonprescription hypnotics in a Canadian elderly population. Can. J. Clin. Pharmacol. 8, 213–221 (2001).
   PubMedGoogle Scholar
• Terzano MG, Rossi M, Palomba V et al. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf. 26, 261–282 (2003).
   PubMed Web of Science ®Google Scholar
• Wagner J, Wagner ML. Non-benzodiazepines for the treatment of insomnia. Sleep Med. Rev. 4, 551–581 (2000).
   PubMed Web of Science ®Google Scholar
• Neubauer DN. Pharmacologic approaches for the treatment of chronic insomnia. Clin. Cornerstone 5, 16–27 (2003).
   PubMedGoogle Scholar
• Edinger JD, Wohlgemuth WK, Radtke RA. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA 285, 1856–1864 (2001).
   PubMed Web of Science ®Google Scholar
• Edinger JD, Sampson WS. A primary care ‘friendly’ cognitive behavioral insomnia therapy. Sleep 26, 177–182 (2003).
   PubMed Web of Science ®Google Scholar
• Hajak G, Muller WE, Wittchen HU et al. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 98, 1371–1378 (2003).
   PubMed Web of Science ®Google Scholar
• McEvoy GK. Benzodiazepines, anxiolytics, sedatives and hypnotics. AHFS Drug Information. American Society of Health-Systems Pharmacists 2395–2448 (2005).
   Google Scholar
• Miller SW. Therapeutic drugs monitoring in the geriatric patient. In: Clinical Pharmacokinetics. Murphy JE (Ed.). American Society of Health-System Pharmacists, USA, 433–474 (2005).
   Google Scholar
• Longo LP, Parran T Jr, Johnson B et al. Addiction: part II. Identification and management of the drug-seeking patient. Am. Fam. Physician 61, 2401–2408 (2000).
   PubMed Web of Science ®Google Scholar
• Soyka M, Bottlender R, Moller HJ. Epidemiological evidence for a low abuse potential of zolpidem. Pharmacopsychiatry 33, 138–141 (2000).
   PubMed Web of Science ®Google Scholar
• Perlis ML, Smith MT, Cacialli DO et al. On the comparability of pharmacotherapy and behavior therapy for chronic insomnia. Commentary and implications. J. Psychosom. Res. 54, 51–59 (2003).
   PubMed Web of Science ®Google Scholar
• Balkrishnan R, Rasu R, Rajagopalan R. Physician and patient determinants of the treatment of sleep difficulties in out-patient settings in the United States. Sleep 28, 715–719 (2005).
   PubMed Web of Science ®Google Scholar
• Benca RM. Consequences of insomnia and its therapies. J. Clin. Psychiatry 62, 33–38 (2001).
   PubMed Web of Science ®Google Scholar
• Hajak G, Bandelow B, Zulley J et al. ‘As needed’ pharmacotherapy combined with stimulus control treatment in chronic insomnia-assessment of a novel intervention strategy in a primary care setting. Ann. Clin. Psychiatry 14, 1–7 (2002).
   PubMedGoogle Scholar
• Culpepper L. Generalized anxiety disorder in primary care: emerging issues in management and treatment. J. Clin. Psychiatry 63, 35–42 (2002).
   PubMed Web of Science ®Google Scholar
• Martin SA, Aikens JE, Chervin RD. Toward cost-effectiveness analysis in the diagnosis and treatment of insomnia. Sleep Med. Rev. 8, 63–72 (2004).
   PubMed Web of Science ®Google Scholar
• Morin CM. Measuring outcomes in randomized clinical trials of insomnia treatments. Sleep Med. Rev. 7, 263–279 (2003).
   PubMed Web of Science ®Google Scholar
• Vermeeren A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 18, 297–328 (2004).
   PubMed Web of Science ®Google Scholar
• Lippmann S, Mazour I, Shahab H. Insomnia: therapeutic approach. South Med J. 94, 866–873 (2001).
   Google Scholar
• Rajput, V. & Bromley, S. M. Chronic insomnia: a practical review. Am. Fam. Physician 60, 1431 (1999).
   PubMed Web of Science ®Google Scholar